Viyash Scientific Ltd Share Price

₹193.10 9.90 (5.40%) BSE
as updated on 01-Apr-2026 16:59 | Sector - Healthcare

Day Range

  • Day's Low:184.00
  • Day's High:195.20

  • 52 Week Low111.00
  • 52 Week High260.30

Viyash Scientific Ltd's key Fundamentals

Market Cap ₹8,003 Cr.
P/E Ratio 104.2
TTM EPS 0.2
P/B Ratio 8.90
ROE 3.92
Debt to Equity 0.73
Face Value 2
BVPS 28
3 Year Sales Growth 3.17%

Viyash Scientific Ltd's Share Price Returns

1 Day 5.40%
1 Week -0.90%
1 Month -4.00%
3 Months -8.00%
6 Months -4.90%
1 Years 41.40%
3 Years 164.50%
5 Years -21.10%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Viyash Scientific Ltd Shareholding Pattern

Promoters

(61.41%)

Institutions

(10.52%)

Non-Institutions

(28.06%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Viyash Scientific Ltd

P I Drugs & Pharmaceuticals Ltd. established in 1991 is a leading manufacturer, exporter of specialized quality formulations having an objective of fulfilling the diverse demands of pharmaceutical industry.

P I Drugs & Pharmaceuticals Ltd. specializes in the manufacturing of the formulation belonging to anthelmintic & anti-parasitic segment.

In September 2007 PI Drugs purchased the pharma division of Transchem Limited.

The company is engaged in the business of human health & animal health and enjoys high Image for distribution in domestic as well as international markets.

They have a specialized and dedicated WHO - GMP accredited manufacturing plant for the manufacture of API's. It exports to all major markets like Europe, South America, Australia, Asia and Africa.

They started with the introduction of Albendazole and has developed core competency in chemistry of Benzimadazole in very short time.

Product range of the company includes:

Human / Veterinary Formulations

  • Diminazene Diaceturate
  • Toldimfos Sodium
  • Quinapyramine
  • Triclabendazole
  • Albendazole
  • Fenbendazole
  • Oxyclozanide
  • Niclosamide
  • Frusemide
  • Mebendazole

Honey Bee Medicine

  • Pizitol®
  • Apistonic®
  • Transprim®

Human / Veterinary API's

Veterinary API’s

  • Albendazole USP/EP/BP
  • Fenbendazole BP/ EP/BP VET
  • Oxfendazole EP/BP VET
  • Mebendazole USP/EP/BP/POLY 'C'

Human API's 

  •  Pentamidine Isethionate
  •  Ramipril EP / BP
  •  Frusemide USP / EP / BE
  •  Cetrizine DI HCL BP / EP
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 184.00
  • Day's High: 195.20

  • 52 Week Low111.00
  • 52 Week High260.30

Viyash Scientific Ltd's key Fundamentals

Market Cap ₹8,003 Cr.
P/E Ratio 104.2
TTM EPS 0.2
P/B Ratio 8.90
ROE 3.92
Debt to Equity 0.73
Face Value 2
BVPS 28
3 Year Sales Growth 3.17%

Viyash Scientific Ltd's Share Price Returns

1 Day 5.40%
1 Week -0.90%
1 Month -4.00%
3 Months -8.00%
6 Months -4.90%
1 Years 41.40%
3 Years 164.50%
5 Years -21.10%
10 Years 0%

Investment related blogs

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×